Skip to content

BillionToOne, Inc.

BLLN

CIK 0002070849 · Services-Medical Laboratories · Nasdaq

← back to feed
Revenue (TTM)
$289.29M
+100.0% YoY Q1 Mar 2026
Net Income (TTM)
$4.79M
+117.9% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$1.42
+103.4% YoY Q1 Mar 2026
Gross Margin
67.6%
Q1 Mar 2026
Operating Margin
4.3%
Q1 Mar 2026
Net Margin
1.7%
Q1 Mar 2026
Free Cash Flow (TTM)
$15.71M
Q1 Mar 2026
Cash
$537.45M
Q1 Mar 2026
Total Debt
$57.23M
Q1 Mar 2026
Shares Outstanding
11.18M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings